This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Correction: IL‑6‑mediated tumorigenicity and antioxidant state in squamous cell carcinoma cells are driven by CD109 via stabilization of IL‑6 receptor‑alpha and activation of STAT3/NRF2 pathway.
Experimental hematology & oncology · 2025
IL-6-mediated tumorigenicity and antioxidant state in squamous cell carcinoma cells are driven by CD109 via stabilization of IL-6 receptor-alpha and activation of STAT3/NRF2 pathway.
Experimental hematology & oncology · 2025
Latest funding
- $1,000,000
Decoding Breast Cancer: How Intrinsic Factors and Distinct Tissue Microenvironments Collaboratively Drive Breast Cancer Initiation
CIHR · 2025 · Co-investigator
- $600,000
Canada Reseach Chair - Tier 2
CIHR · 2023 · Nominated PI
- $450,000
Investigating host cell vulnerabilities for human papilloma virus infection and risks for cancer development
CIHR · 2023 · Nominated PI
2 publications.
Correction: IL‑6‑mediated tumorigenicity and antioxidant state in squamous cell carcinoma cells are driven by CD109 via stabilization of IL‑6 receptor‑alpha and activation of STAT3/NRF2 pathway.
Hassan A, Kungyal T, Zhou S, Blati M, Finnson K, Bertos N, Golabi N, Sadeghi N, Loganathan S, Philip A
IL-6-mediated tumorigenicity and antioxidant state in squamous cell carcinoma cells are driven by CD109 via stabilization of IL-6 receptor-alpha and activation of STAT3/NRF2 pathway.
Hassan A, Kungyal T, Zhou S, Blati M, Finnson K, Bertos N, Golabi N, Sadeghi N, Loganathan S, Philip A
Decoding Breast Cancer: How Intrinsic Factors and Distinct Tissue Microenvironments Collaboratively Drive Breast Cancer Initiation
Principal investigators: McCaffrey, Luke M; Prakash, Ipshita; Ursini-Siegel, Giuseppina
Keywords: Breast Cancer; Clinical Cancer Samples; Crispr; Early Cancer Detection; Machine Learning/Ai; Mouse Models Of Cancer; Multiplexed Imaging; Secondary Prevention
Canada Reseach Chair - Tier 2
Principal investigators: Loganathan, SAMPATH K
Keywords: Crc
Investigating host cell vulnerabilities for human papilloma virus infection and risks for cancer development
Principal investigators: Loganathan, SAMPATH K
Keywords: Animal Models Of Cancer; Crispr; Hnscc; Hpv; Opscc
Understanding human Papilloma virus and Epstein-Barr virus related oncological mechanisms in head and neck squamous cell carcinoma
Principal investigators: Loganathan, SAMPATH K; Cheong, Sok Ching; Luxenburg, Chen
Keywords: Crispr; Cytoskeletal Proteins; Epstein-Barr Virus Ebv; Human Papilloma Virus- Hpv; Mouse Models Of Cancer; Non-Communicable Diseases- Head And Neck Cancer
Defining the role of fetal reprogramming in the gut epithelium in health and disease.
Principal investigators: Gregorieff, Alex
Keywords: Colorectal Cancer; Conditional Ko Mice; Fetal Gut Development; Fetal Reprogramming; Hippo Signaling; Intestinal Regeneration; Intestinal Stem Cell; Organoids; Tgf-Beta Signaling; Wnt Signaling
Deciphering the role of metabolic genes in head and neck squamous cell carcinoma
Principal investigators: Loganathan, SAMPATH K
Keywords: Cancer Metabolism; Head And Neck Squamous Cell Carcinoma Hnscc; In Vivo Crispr; Mouse Models Of Cancer
Deciphering the role of metabolic genes in head and neck squamous cell carcinoma
Principal investigators: Loganathan, SAMPATH K
Keywords: Cancer Metabolism; Head And Neck Squamous Cell Carcinoma Hnscc; In Vivo Crispr; Mouse Models Of Cancer
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Anie Philip and Nader Sadeghi: 2 shared papers
- Anie Philip and SAMPATH Loganathan: 2 shared papers
- Nader Sadeghi and SAMPATH Loganathan: 2 shared papers
- Otolaryngology
- Surgery
Co-authors at McGill University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.